ArticleObesity surgery2023
Diabetes Mellitus Remission in Patients with BMI > 50 kg/m
Article in Obesity surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 30 citations in OpenAlex.
- Understanding Remission of Long-Term Conditions Through Electronic Health Records: Scoping Review.Journal of medical Internet research · 2026Article
- Metabolic and Bariatric Surgery: The Contraindications of the Past are the Indications of the Future.Current obesity reports · 2026Review
- Effect of bariatric surgery and pharmacological treatments on cardiovascular risk factors for adults with overweight and obesity: a systematic review and network meta-analysis.International journal of surgery (London, England) · 2026Article
- Predicting Type 2 Diabetes Remission After Bariatric Surgery: The Role of Homeostatic Model Assessment of Insulin Resistance (Homa-IR), Visceral Adiposity Index (Vai) and Triglyceride-Glucose (TyG) Index.Journal of clinical medicine · 2025Article
- Incretin-based approaches for type 2 diabetes therapy: effects on circulating cytokines and adipocyte's secretome.BMC endocrine disorders · 2025Article
- Advances in Metabolic Bariatric Surgeries and Endoscopic Therapies: A Comprehensive Narrative Review of Diabetes Remission Outcomes.Medicina (Kaunas, Lithuania) · 2025Review
- Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks.Obesity pillars · 2024Review
- Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects.Journal of clinical medicine · 2024Article
- Rare Complications Following Laparoscopic Sleeve Gastrectomy.Journal of clinical medicine · 2024Review
- Revisional Bariatric Surgery After Roux-en-Y Gastric Bypass for Bile Reflux: a Single-Center Long-Term Cohort Study.Obesity surgery · 2024Article
- Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes.Surgical endoscopy · 2024Article
- Weight loss outcomes with semaglutide based on diabetes severity using the individualized metabolic surgery score.EClinicalMedicine · 2024Article
- The association between microvascular and macrovascular diseases and diabetes remission after bariatric surgery.Surgical endoscopy · 2024Article
- One Anastomosis Gastric Bypass vs. Sleeve Gastrectomy in the Remission of Type 2 Diabetes Mellitus: A Retrospective Analysis on 3 Years of Follow-Up.Journal of clinical medicine · 2024Article
- The Impact of Artificial Sweeteners on Human Health and Cancer Association: A Comprehensive Clinical Review.Cureus · 2023Review
- Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control Study.Obesity surgery · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionType 2 diabetes mellitus (T2DM) is a common comorbidity associated with obesity, particularly in patients with body mass index (BMI) ≥ 50 kg/m
methodsThis was a retrospective study of the electronic medical records of all patients with BMI ≥ 50 kg/m
resultsA total of 279 patients with T2DM (65% females, mean age 51.0 ± 11.7 years, 89% white, BMI 56.6 ± 5.9 kg/m
conclusionsIn this cohort of patients with BMI ≥ 50 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.